Bladder - Automated Imaging

FDA cleared for bladder samples hybridized with Abbott’s UroVysion™ FISH probe

BioView’s automated application for the imaging and analysis of cells in voided urine samples facilitates and eases case review and reporting processes.

The ability to efficiently scan, classify and analyze cells hybridized with Abbott’s UroVysionTM Bladder Cancer Kit, enables fast and accurate detection of aneuploidy for chromosomes 3, 7, 17 and loss of the 9p21 locus.

The application is not available in all markets.

For additional information visit our Regulatory Approvals Page

Features:

FDA cleared and CE marked
Rapid scan and analysis of cells hybridized with fluorescent markers
Optimized automated scanning to specific regions showing morphological abnormal nucleus size or shape and DAPI staining pattern
Smart Stop determines whether to scan the entire slide, stop after a pre-set number of cells, or stop after a pre-set number of abnormal cells
Sample quality meter automatically skips poorly hybridized samples to maximize system throughput
Automated exclusion of White Blood cells during scan, for improved detection of positive cells
Automated identification of cell clumps, for improved detection of abnormal individual cells
Simple review and reporting from within the laboratory or a remote location, through BioView’s line of review and analysis workstations – Solo, Solo Touch and SoloWeb